BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and the prevention of infectious disease, announced today that it has appointed Dr Kapil Dhingra to the Board of Directors as a Non-Executive.
Read more on Business Wire via Yahoo! Finance